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Highlights:  
 Recessive mutations in the ECEL1 gene cause heterogeneous contractural phenotypes  
 We describe 7 novel patients from 4 unrelated families with ECEL1 gene mutations  
 We provide long-term clinical follow-up for 5 patients with ECEL1 gene mutations 
 We observed myopathic features, core-like areas and nCAM positive fibres on 
histopathology 
 We provide novel pathomechanical insights into ECEL1 gene related conditions 
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Abstract 
Autosomal recessive mutations in the ECEL1 gene have recently been associated with a wide 
phenotypic spectrum including severe congenital contractural syndromes and distal 
arthrogryposis type 5D (DA5D). Here, we describe four novel families with ECEL1 gene 
mutations, reporting 15 years of follow-up for five patients and detailed muscle pathological 
description for three individuals. In particular, we observed mild myopathic features, 
prominent core-like areas in one individual, and presence of nCAM positive fibres in three 
patients from 2 unrelated families suggesting a possible problem with innervation. Our 
findings expand current knowledge concerning the phenotypic and pathological spectrum 
associated with ECEL1 gene mutations and may suggest novel insights regarding the 
underlying pathomechanism of the disease. 
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Highlights:  
 Recessive mutations in the ECEL1 gene cause heterogeneous contractural phenotypes  
 We describe 7 novel patients from 4 unrelated families with ECEL1 gene mutations  
 We provide long-term clinical follow-up for 5 patients with ECEL1 gene mutations 
 We observed myopathic features, core-like areas and nCAM positive fibres on 
histopathology 
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Introduction 
Distal Arthrogryposis (DA) is a congenital limb malformation disorder characterized by 
multiple joint contractures, including camptodactily, overriding fingers, clenched fists, ulnar 
deviation of the wrist and/or clubfoot [1, 2]. DAs are genetically and phenotypically 
heterogeneous, and to date 13 distinct OMIM-listed DAs subtypes have been defined on the 
basis of phenotypic features. Known DA genes typically encode for sarcomeric proteins of 
the contractile apparatus: MYH3 (DA2A, 2B and DA8), MYH8 (DA7), MYBPC1 (DA1B), 
TPM2 (DA1A), TNNI2 (DA2B), TNNT3 (DA2B), PIEZO2 (DA3 and DA5), all transmitted 
with autosomal dominant inheritance with the exception of rare families segregating 
recessive pathogenic PIEZO2 variants [3]. There is a considerable genetic and clinical 
overlap with the congenital myopathy spectrum, in particular nemaline myopathies and 
myosinopathies [4]. 
In 2013, recessive mutations in the Endothelin-converting Enzyme-Like 1 (ECEL1) gene 
were identified in patients presenting with features suggestive of DA (DA5D), characterized 
by congenital limited knee flexion, hip dislocation, scoliosis and ptosis [5, 6]. Since then, 41 
patients from 23 families with pathogenic ECEL1 gene variants have been reported [5-13]. 
The phenotype reported so far is characterised by congenital contractures affecting mostly the 
distal joints of upper and lower limbs, in particular fingers and knees, club feet, hip 
dislocation, short stature and scoliosis. Ocular findings, such as ptosis, severe 
ophthalmoplegia and astigmatism, as well as micrognathia, tongue groove and cleft palate are 
also common. An even more severe presentation with multiple pterygia and foetal 
arthrogryposis has also been described [7, 9].  
The ECEL1 gene encodes for the endothelin-converting enzyme-like 1 (ECEL1), a type II 
integral transmembrane zinc metalloprotease [14]. Although the exact substrate of ECEL1 
remains unknown, in vitro studies of transfected cells suggested it localizes to the 
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endoplasmic reticulum and to a lesser extent to the cell surface [15]. The ECEL1 protein is 
thought to play a role in neural and subsequently neuromuscular junction (NMJ) development 
during foetal life in mice and humans [14, 16, 17]. Indeed, mice deficient in the homologous 
murine gene, Ecel1, die of respiratory failure immediately after birth [17, 18], and the rodent 
homologue knock-in animal model shows significant decrease of peripheral motor axons, 
arborization and failure of NMJs formation, suggesting this could be a key 
pathophysiological mechanism of ECEL1-related conditions [19].  
Herein, we report 7 novel patients from 4 unrelated families with pathogenic ECEL1 variants 
and provide long-term clinical follow-up for 5 patients. We also provide novel insights into 
the pathological features associated with ECEL1 gene mutations, further expanding our 
knowledge concerning this rare condition and its pathogenesis. 
 
Materials and Methods 
The study was approved by the Institutional Ethical Review Board of the University College 
London Institute of Child Health and Great Ormond Street Hospital in the UK. Families were 
recruited among the children attending the neuromuscular centres in London, Oswestry and 
Glasgow, UK. Informed consent was obtained from all individuals included in this study or 
from their parents or legal guardians. The consent and local review board approval were in 
accordance with the UK10K project ethical framework (http://www.uk10k.org/ethics.html). 
Genomic DNA was extracted from blood using standard procedures. Whole exome 
sequencing (WES) was performed in probands from family A and B (Fig.1). Details for WES 
analysis and filtering process are described elsewhere [20]. Variants identified by exome 
sequencing were confirmed by Sanger sequencing. ECEL1 gene analysis in family C and D 
was performed as part of a next generation sequencing analysis of a panel of genes implicated 
in congenital myopathies, at the Viapath laboratory, Guys and St Thomas Hospital in 
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London, UK. Assessment of pathogenicity was carried out using bioinformatics software 
Alamut (http://www.interactive-biosoftware.com). Further details for panel analysis and 
Sanger sequencing are available on request.  
Muscle biopsies were available from individuals from families A and B. Histological, 
histochemical and immunohistochemical studies were performed using standard techniques 
[21] with additional immunohistochemical labelling performed using the Menarini kit or on a 
Ventana Discovery Ultra automated machine.   
Conventional T1- weighted Muscle MRI images of lower limbs were obtained for one 
proband from family A. 
Electromyography (EMG) was performed using standardised techniques [22]. Jitter 
measurements were made by the technique of SPACE, which is a modification of stimulated 
single fibre EMG [23]. 
Results 
Clinical features  
Family A: Patient A1 and A2 were born to healthy first degree cousin parents of Irish origin 
(Fig. 1, Table 1). Pregnancy for patient A1 was complicated by poor foetal movements, 
premature rupture of membranes at 30 weeks and prolonged breech position. At birth, she 
presented with bilateral contractures of fingers, knees and feet, and a cleft palate. Slow 
feeding and choking persisted during childhood despite cleft repair at 10 months. She sat and 
walked at 1 and 3 years, respectively. At age 4 years, she was able to hop and slowly run, but 
required a handrail to climb stairs. At age 8 years, she had mild facial weakness with 
temporomandibular joint contractures, and deep central groove in the tongue. She showed 
severe bilateral upper and lower limb contractures, digital webbing, calcaneo-cavus posture 
of the feet and flexion deformity of the toes (Table 1, Fig. 2e, f). Spine was straight but rigid. 
She presented mild proximal upper limb weakness. Speech was nasal in tone. Mild learning 
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difficulties were diagnosed at 8 years. She remained under follow up until age 26 years. Over 
the years, joint contractures remained fixed. In her teens, she developed exercise intolerance 
with declining walking distance, and progressive weakness in neck, shoulders, and hips 
flexors. At age 21 years, forced vital capacity (FVC) was 48% of the predicted value and 
remained stable over the following years. She had tendon release of toes (at 13 years), fingers 
(17 years) and feet (24 years). Creatine kinase (CK) levels were normal. EMG of the 
peroneus muscle at age 21 years was myopathic and jitter measurement was normal, 
indicating normal NMJ function.  
Patient A2, born at 37 weeks by caesarean section (CS) for breech presentation, presented at 
birth with extension contractures of elbows and knees, flexion contractures of fingers, 
bilateral ptosis and undescended testes. He walked at 12 months, and was able to climb stairs 
on all fours at 3 years. At age 8 years, he showed mild facial weakness, high-arched palate, 
central tongue groove and bilateral upper and lower limb contractures (Fig. 2a-d). Spine was 
rigid with a mild thoracic scoliosis. He had surgical correction of left tibial torsion (at 6 
years), orchidopexy and ptosis surgery (at 8 years). CK was normal. FVC was 70% at age 18 
years and remained stable. At age of 22 years, he was able to walk up to about one kilometre. 
EMG at age 18 years was myopathic and jitter measurement was normal, excluding a NMJ 
dysfunction.  
Patient A3, first degree cousin of patient A1 and A2, born from first degree cousin parents, 
showed bilateral fixed adducted thumbs and flexion contractures of proximal interphalangeal 
joints at birth (Fig. 2g-h). She had limitation in hip abduction, fixed flexion contractures of 
knees and vertical talus with mild pterygia of fingers and knees. Psychomotor development 
was within normal limits. At age 7 years, she had mild facial weakness with ptosis, mild 
proximal limb and neck extension weakness, and fine motor skills difficulties due to finger 
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contractures. She had multiple orthopaedic tendon-release surgeries from age 8 to 12 years. 
CK levels were normal.  
Family B: Patient B1, the second child of unrelated healthy parents from Scotland, was born 
at 39 weeks of gestation by elective CS for breech position and reduced foetal movements, 
partly due to fixed knee joint contractures (Fig. 1, Table 1). At birth, hip flexors and knee 
extensors contractures and reduced shoulder movements were noted. He had bilateral ptosis, 
epicanthic folds with limited ability to close the eyes, neck webbing and bilateral 
cryptorchidism. He walked at 18 months (Fig. 2i). At age 5 years, he was able to walk a few 
miles, but had difficulties climbing stairs due to knee contractures. At age 14 years, he 
developed scoliosis and had corrective surgery at age 17 years. Restrictive pulmonary 
syndrome was diagnosed at age 15 years and he started overnight non-invasive ventilation at 
age 17 years. At age 20 years, he had a genetic diagnosis of myotonic dystrophy type 1 
(DM1), after identification of a pathogenic CTG repeats expansion in the DMPK gene, 
following clinical and genetic diagnosis of DM1 in the patient’s father. At age 24 years, he 
remained ambulant. He showed facial weakness, bilateral ptosis, central furrowing of the 
tongue, upper and lower limbs proximally weakness but no myotonia (Fig. 2j-k, m and o). 
CK levels were normal. 
Patient B2, the younger sister of patient B1, was born at 37 weeks of gestation by elective CS 
for extended breech presentation. Multiple joints contractures were detected on antenatal 
scans. At birth, she presented with cleft palate, bilateral hip luxation, knee contractures in 
extension and dorsiflexed feet. Psychomotor development was normal, but fine motor skills 
were affected by fingers contractures. Scoliosis was diagnosed at age 13 years. At age 22 
years, she presented with incomplete eye closure and a convergent strabismus, central 
furrowing of the tongue, neck and fingers webbing, finger flexion contractures and proximal 
weakness at upper and lower limbs (Fig.2l and 2n). She was ambulant only for short 
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distances, using a wheelchair outdoors. She had a cleft repair at 6 months, strabismus 
correction at 7 years and spinal surgery at 17 years. CK level was normal. Genetic testing 
excluded DM1. 
Family C: patient C1 was born to healthy first-cousin parents from India (Fig. 1, Table 1). 
Decreased foetal movements were noted in pregnancy and she was born by CS at term for 
breech position. At birth, she presented with extension contractures at the knees and fixed 
adducted right thumb but no finger contractures. Feet were in dorsiflexion and abduction, but 
flexible. She sat at 6 months and walked with support at 12 months. At age 2 years and 4 
months, she was ambulant, but unable to run or jump. She had limited knee flexion and 
calcaneovalgus feet deformities. Thumbs were held in a partially reducible adducted position. 
She had no muscle weakness. CK, muscle ultrasound and EMG at 16 months was normal.  
Family D: patient D1 was born to unrelated parents from Somalia (Fig. 1, Table 1). An older 
brother was reported to have congenital contractures of lower limbs, but no further 
information was available. Flexed elbows, clenched hands, extended knees and clubfeet were 
noted on antenatal scans from 20th weeks. CS was performed at 39 weeks for breech 
position. At birth she showed bilateral flexion contractures of elbows, fingers and hips, 
bilateral extension contractures of the knees and right talipes equino varus deformities. She 
walked independently at 3 years and at age 4 years, she was unable to run or jump because of 
fixed knee contractures. Speech and language was mildly delayed. Ankle tendon release was 
performed at 4 months of age, followed by right hip osteotomy at 17 months. CK levels and a 
muscle ultrasound were normal. EMG at 1 month of age was mildly myopathic and jitter 
measurement was normal. 
Muscle MRI Imaging 
Muscle MRI scan of the lower limbs from patient A1 at age 22 years showed symmetrical 
reduction of thigh and calf muscle bulk, particularly of biceps femoris, posterior calf 
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compartment and extensor digitorum longus muscles (Fig. 3). There was also some increase 
in abnormal signal within the sartorius and the posterior compartment in the thigh (Fig. 3). 
Muscle pathology 
Muscle biopsies were available from patient A1 (vastus lateralis, taken at age 12 years), A2 
(peroneal muscles, taken at age 6 years when tibial torsion was surgically corrected) and B2 
(vastus lateralis, taken at age 14 years). Variation in fibre size was minimal in patient A1 but 
was mildly abnormal in A2 and B2 (Fig. 4a and 4d). A few internal nuclei and predominance 
of type1/slow fibres were observed, particularly in B2 (Fig. 4b and 4e). Several small core-
like areas, particularly in type 1 fibres, were observed in patient A2 (Fig. 4b) and electron 
microscopy suggested that these may have been related to abnormal mitochondrial 
distribution with only minimal myofibrillar disruption. Fibres positive for developmental and 
foetal myosin were not a feature indicating no fibre degeneration/regeneration. 
Immunolabelling of neuronal cell adhesion molecule (nCAM) of all 3 biopsies showed 
clusters of positive fibres with abnormal sarcolemmal and internal labelling suggesting an 
abnormality of innervation of some fibres (Fig. 4c and 4f).  
Genetics  
Whole exome sequencing (WES) analysis, performed in patient A1, identified a novel 
homozygous missense variant (c.589G>A; p.(Gly197Ser)) in exon 2 of the ECEL1 gene. 
Pathogenicity prediction software Alamut predicted this variant to be deleterious. WES 
analysis of patient B1 revealed a homozygous frameshift variant (c.2005_2006delAC; 
p.(Thr669fs)) in exon 15 of the ECEL1 gene. This variant has not been reported previously 
and pathogenicity prediction software considered it to be deleterious. Segregation studies 
confirmed the presence of the novel ECEL1 homozygous variants in all affected individuals 
from Family A and B, respectively, and in heterozygosity in healthy parents and siblings, 
further supporting their pathogenicity (Fig.1). Next generation panel gene sequencing showed 
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the presence of previously identified homozygous ECEL1 gene mutations (c.1210C>T; 
p.(Arg404Cys) and c.1470G>A; p.(Trp490Ter)) in patient C1 and D1, respectively [5, 13]. 
Parents were confirmed to be heterozygous carriers.  
 
Discussion 
In this study, we provide novel clinical, pathological and genetic insights into a recessive 
form of contractural syndrome associated with ECEL1 gene mutations. In particular, we 
describe 7 novel patients with ECEL1 gene mutations in addition to the 41 individuals 
previously reported [5-13]. The clinical analysis of our cohort indicates that the most 
common clinical findings are knee (7/7) and finger contractures with adducted thumb (7/7), 
ankle contractures (6/7), clubfeet (6/7) and hip contractures (5/7), similarly to previous 
reports (Table 1). Limitation of shoulder movements was more common than previously 
reported in the literature (4/7, 57% versus 34%) suggesting that the upper limbs are also often 
affected. Facial weakness and central tongue groove were more often observed in our cohort 
(5/7, 71% versus 35% and 4/5, 80% versus 43%, respectively). We also report for the first 
time temporomandibular contractures in one patient. Bilateral ptosis was the main 
ophthalmological finding in our cohort (5/7, 71% versus 76% in the literature), followed by 
strabismus (1/7, 14% versus 15% in the literature). Ophthalmoplegia, previously reported in 
9% of patients [5, 12], wasn't observed in any of our patients. Few published data were 
available to date on antenatal findings in ECEL1 gene patients. One report indicated AMC in 
two pregnancies terminated around 1st trimester [9]. In our cohort, we observed a prevalent 
prenatal presentation, with reduced foetal movements (4/7), antenatal contractures (3/7) and 
breech presentation necessitating CS in most patients (6/7), further emphasising the foetal 
onset of the condition. Interestingly, both male patients from this cohort also had 
cryptorchidism.  
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We also report on long term follow-up of 4 adults with ECEL1 gene related condition (A1, 
A2 and B1, B2), providing valuable information on evolution and long term complications of 
this rare condition not available so far. Proximal weakness of upper and lower limbs was 
reported in about half of our patients (4/7), with progression over time. Ambulation was 
preserved in all patients, but we noted limitation of walking distance from the second decade 
of life in all older patients (4/4). Patient B1 had a coincidental diagnosis of DM1 but at last 
examination at age 24 years, he did not show complications typical of this coexisting 
condition. Progressive scoliosis was relatively common both in our cohort and in the 
literature (3/7, 43% versus 42%), and was associated with respiratory compromise in about 
two of our patients. Previously, Shaheen et al. reported severe respiratory complication 
secondary to thoracic deformity, leading to death in a 17-year-old patient [13]. Of note, 
cardiac function was normal in all patients. It is unclear if the severity of the clinical picture 
at birth is determinant of the severity of the disease course and later complications, but 
standardized follow-up and analysis of further patients might help to clarify this point. 
Overall, these clinical findings highlight the complex clinical course of ECEL1 gene related 
conditions and advocate for an appropriate, multidisciplinary follow-up of affected patients 
with in particular neuromuscular, orthopaedics and respiratory specialist inputs.  
To date, skeletal muscle biopsy has been reported only from a minority of ECEL1 patients 
(6/36) and histopathological findings were variable [5, 9]. Features suggestive of 
centronuclear myopathy were observed in two foetuses with severe AMC but the foetuses 
were only 13-14 weeks of gestation and these findings could be related to development [9]. In 
our cases, the lack of developmental and foetal myosin not only suggested an absence of 
muscle fibre regeneration but that maturation, at least in terms of myosin expression, had 
occurred normally. In common with published cases, type 1/slow fibre predominance and 
mild fibre size variation were predominant features. Abundant intracellular lipid was 
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observed in a few reported patients, with no evidence of structural abnormalities or features 
of denervation [5]. Excess lipid was not seen in our cases. In our series, we observed mild 
myopathic features and for the first time, presence of prominent core-like areas in one 
individual which initially raised the possibility of a core myopathy (Fig. 4). We also found 
occasional internal nuclei in three biopsies but not the appearance of a centronuclear 
myopathy (Fig. 4). Furthermore, in three patients (A1, A2 and B2), we noted the presence of 
fibres positive for nCAM suggesting a possible problem with innervation of some fibres 
(Fig.4c and 4f). This finding supports the hypothesis, gathered from the Ecel1 mouse model, 
that the lack of peripheral motor axon arborisation contributes to the pathogenesis of DAD5 
[19]. Analysis of muscle biopsies of further patients with ECEL1 gene mutations might help 
to clarify this point and to characterize further the histopathological spectrum of this 
condition, assessing if the condition is neurological rather than muscular in origin. 
Interestingly, we observed patchy MRI pattern of involvement in selected muscles (Fig. 3), a 
feature more in keeping with a neurogenic rather than a myopathic aetiology [24]. 
Nevertheless, the result of the EMG examination was more in keeping with a myopathic 
process in three out of four patients tested, similarly to that reported by Dieterich et al., who 
however also indicated neurogenic signs in one patient at a second, more extensive 
investigation [5]. The jitter measurement was normal in three patients of our series examined 
by this means, effectively ruling out a neuromuscular junction defect. This is relevant in view 
of the suggestion, from the Ecel1 mouse model, of a contribution of the neuromuscular 
junction in the disease pathogenesis [19]. From a clinical diagnostic point of view, in view of 
the major clinical and pathological overlap with similar myopathic contractural syndromes, 
we strongly suggest adding ECEL1 gene into panel of genes responsible for congenital 
myopathies and / or distal arthrogryposis.  
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The allelic spectrum of ECEL1 gene related conditions is wide and no clear genotype 
phenotype correlations have been reported to date. Interestingly, homozygous or compound 
ECEL1 gene mutations leading to truncated protein do not associate with a severe 
presentation [5, 6, 13]. Conversely, a homozygous missense variant affecting a highly 
conserved amino acid of the catalytic domain of the protein (c.2023G>A p.(Ala675Thr)) 
caused severe foetal presentation with AMC [9]. We identified two novel ECEL1 mutations, 
a missense change (c.589G>A; p.(Gly197Ser) in family A) affecting a highly conserved 
residue in exon 2, and a frame shift variant (c.2005_2006delAC; p.(Thr669fs) in family B) in 
exon 15 involved in the catalytic function of the protein. Patients from our cohort with 
homozygous missense variants (families A and C) did not significantly differ in severity 
compared to those with homozygous truncating mutations (families B and D). Coexisting 
mutations in other genes were potentially implicated in the increased severity of the 
phenotypes of some patients and the intrafamiliar variability described here and in previous 
reports could potentially support this suggestion [5, 8].  
In summary, our findings further expand the knowledge on ECEL1 gene related contractural 
disorders, confirming these as variable phenotypes, ranging from severe AMC to milder 
forms of DA5D. The long-term follow up data as well as the novel clinical and pathological 
findings reported here will be of diagnostic and prognostic value for clinicians and families. 
Further investigations are warranted to characterize better the function of the ECEL1 protein 
and the effect of the mutations on nerve and muscle function, in order to recognise the full 
spectrum of associated clinical and pathological features.  
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Table 1: Clinical features of patients with ECEL1 gene mutations 
PATIENT A1 A2 A3 B1 B2 C1 D1 
Total 
(N=7) 
Literature
* 
 
Prenatal findings 
Gestational age 
at birth 
37 
wks 
38 
wks 
39 
wks 
39 
wks 
37 
wks 
40 
wks 
39 
wks 
  
Reduced foetal 
movements 
+ + - + - + - 4/7 (57%) nr 
Breech 
presentation 
+ + - + + + + 6/7 (86%) nr 
Delivery by CS + + - + + + + 6/7 (86%) nr 
Antenatal 
contractures 
- - - + + - + 3/7 (43%) nr 
Age at last 
examination  
(years) 
26 22 12 24 22 3 4  nr 
Sex F M F M F F F  nr 
Psychomotor development 
Age at Walking 3y 12m 12m 18m 18m 2y 3y  nr 
Learning 
difficulties 
+ + - - - U + 3/6 (50%) nr 
Facial features 
Facial 
dysmorphism 
+ + + + - - + 5/7 (71%) 14/20 (70%) 
Facial weakness + + + + - - + 5/7 (71%) 7/20 (35%) 
Bilateral ptosis - + + + + - + 5/7 (71%) 26/34 (76%) 
Ophthalmoplegia - - - - - - - 0/7 (0%) 3/34 (9%) 
Strabismus - - - - + - - 1/7 (14%) 5/34(15%) 
Cleft palate + - - - + - - 2/7 (29%) 3/34 (9%) 
Central groove 
in tongue 
+ + - + + U U 4/5 (80%) 10/23 (43%) 
Micrognathia + - + - + - + 4/7 (57%) 14/24 (58%) 
Neck webbing - -  + + - - 2/7 (29%) 7/13 (54%) 
Spine 
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Scoliosis - + - + + - - 3/7 (43%) 13/31 (42%) 
Upper limbs 
Finger 
contractures or 
Adducted thumbs 
+ + + + + + + 
7/7 
(100%) 
34/34 
(100%) 
Limitation of 
shoulder 
movements 
+ + - + + - - 4/7 (57%) 11/32 (34%) 
Limitation of 
elbow 
movements 
+ + - - - - + 3/7 (43%) 14/31 (45%) 
Wrist 
contractures 
+ + - - - - - 2/7 (29%) 16/24 (67%) 
Digital webbing + - + - + - - 3/7 (43%) nr 
Lower limbs 
Hip contractures + + + + - - + 5/7 (71%) 28/34 (82%) 
Hip dislocation - - - - + - - 1/7 (14%) nr 
Knee 
contractures 
+ + + + + + + 
7/7 
(100%) 
30/34 (88%) 
Knee webbing - - + - - - - 1/7 (14%) nr 
Ankle 
contractures 
+ + + - + + + 6/7 (86%) 16/24 (67%) 
Rocker bottom 
feet 
+ + + - + + + 6/7 (86%) 30/34 (88%) 
Muscle symptomatology 
Proximal 
weakness 
+ + + - + - - 4/7 (57%) nr 
Distal weakness + + - + + + + 6/7 (86%) nr 
Limited 
ambulation at 
adult age 
+ +  + +   
4/4 
(100%) 
nr 
Respiratory 
insufficiency 
+ at 
21y 
- - 
+ at 
15y 
- - - 2/7 (29%) nr 
Non-invasive 
ventilation 
- - - + - - - 1/7 (14%) nr 
Muscle atrophy + + - + + - - 4/7 (57%) nr 
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Wks: weeks of pregnancy, CS: caesarean section, V: vaginal delivery, y: years, nr: not 
reported, N: number, U: unknown; 
*
Barnett et al., 2014; Dieterich et al., 2013; McMillin et 
al., 2013, Shaaban et al., 2013; Shaheen et al., 2013; Patil et al., 2014, Hamzeh et al., 2017. 
 
Legends  
Figure 1: Pedigrees of 4 DA5D families with ECEL1 gene mutations.  
Arrows indicate the index patient of each family. Question mark indicates that the clinical 
and genetic status of the patient is unknown. Open symbols: unaffected, filled symbols: 
affected, half-filled: carrier, striped symbols: affected by DM1. 
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Figure 2: Clinical images of patients with ECEL1 gene mutations 
Patient A1 at age 8 years (a) and 21 years (b, c, d); patient A2 at age 18 years (e, f); patient 
A3 at birth (g, h); patient B1 at age 18 months (i) and 20 years (j, k, m, o); patient B2 at age 
13 years (l, n). Note bilateral ptosis (a, b, j), central tongue groove (b), proximal weakness at 
upper limbs (c), fingers and thumb contractures (d, f, g, m, o), limited hip extension and 
knees contractures (i), rocker bottom foot (h), and bilateral toe flexion deformities (e). 
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Figure 3: Muscle MRI images of patient with ECEL1 gene mutations 
T1-weighted MRI sequences of pelvic girdle and lower limbs muscle of patient A1 at 12 
years of age (a, b, c, d). Note symmetrical reduction in volume of thigh and calf muscles, in 
particular of biceps femoris in the posterior compartment, posterior calf compartment and the 
peroneus and extensor digitorum longus muscle groups. There is also a patchy increase in 
abnormal signal within the sartorius and the posterior thigh compartment.  
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Figure 4: Histopathology of muscle biopsies of patients with ECEL1 gene mutations 
Peroneal muscle biopsy of patient A2 (a, b, c) and quadriceps muscle biopsy of patient B2 (d, 
e, f). Gomori trichrome (a); nicotinamide adenine dehydrogenase tetrazolium (NADH-TR) (b 
and e); haematoxylin and eosin (d); neural Cell Adhesion Molecule (nCAM) (c, f). Note 
occasional internal nuclei (small arrows), core-like areas (large arrows), type 1 fibre 
predominance, especially in patient B2 (e) and several fibres with positive labelling for neural 
cell adhesion molecule (c, f). 
 
